The University of Michigan Comprehensive Cancer Center is one of 12 sites to join Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.
The University of Michigan Comprehensive Cancer Center has appointed four new leaders to oversee the direction and operation of its research enterprise.
The technique could one day help screen potential cancer treatments based on an individual patient's tumor and help researchers better understand cancer stem cells.
Eric Fearon, M.D., Ph.D., has been named director of the University of Michigan Comprehensive Cancer Center.
A small device implanted under the skin can improve breast cancer survival by catching cancer cells, slowing the growth of tumors.
U.S. News & World Report rankings places the U-M Comprehensive Cancer Center ranks first in Michigan.
Women who engaged on social media after a breast cancer diagnosis expressed more deliberation about their treatment decision and more satisfaction with the path they chose, a new study finds.
More imaging after thyroid cancer treatment identifies recurrence, but it does not always improve survival, a new study suggests.
When a woman is diagnosed with the earliest stage of breast cancer, how aggressive should her treatment be?
For many young women diagnosed with cancer, concerns about fertility can be so important they influence critical decisions about treatment.